Cas 1260587-22-1,(S)-3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID

1260587-22-1

Post Buying Request

Basic information

Product Name: (S)-3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID
Synonyms: (S)-3-AMINO-3-CYCLOPENTYLPROPANOIC ACID;(S)-3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID
CAS NO:1260587-22-1
Molecular Formula: C8H15NO2
Molecular Weight: 157.21
EINECS: N/A
Product Categories: N/A
Mol File: 1260587-22-1.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: /
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (S)-3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID(CAS DataBase Reference)
NIST Chemistry Reference: (S)-3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID(1260587-22-1)
EPA Substance Registry System: (S)-3-AMINO-3-CYCLOPENTYL-PROPIONIC ACID(1260587-22-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1260587-22-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1260587-22-1 Suppliers

Recommended suppliersmore

1260587-22-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1260587-22-1 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,0,5,8 and 7 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1260587-22:
(9*1)+(8*2)+(7*6)+(6*0)+(5*5)+(4*8)+(3*7)+(2*2)+(1*2)=151
151 % 10 = 1
So 1260587-22-1 is a valid CAS Registry Number.

1260587-22-1Upstream product

1260587-22-1Downstream Products

1260587-22-1Relevant articles and documents

2-CYANOPYRROLES AND THEIR ANALOGUES AS DDP-IV INHIBITORS

-

Page/Page column 50, (2010/02/08)

The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV having the formula I: (I) The invention furthermore relates to pharmaceutical compositions comprising the compounds and the use of such compounds for the manufacture of medicaments for treating diseases that are associated with proteins which are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1260587-22-1